172 related articles for article (PubMed ID: 4359292)
1. Cancer in children with primary immunodeficiency diseases.
Kersey JH; Spector BD; Good RA
J Pediatr; 1974 Feb; 84(2):263-4. PubMed ID: 4359292
[No Abstract] [Full Text] [Related]
2. Primary immunodeficiency diseases and cancer: the immunodeficiency-cancer registry.
Kersey JH; Spector BD; Good RA
Int J Cancer; 1973 Sep; 12(2):333-47. PubMed ID: 4365092
[No Abstract] [Full Text] [Related]
3. Occurrence of malignancy in immunodeficiency diseases. A literature review.
Gatti RA; Good RA
Cancer; 1971 Jul; 28(1):89-98. PubMed ID: 4938894
[No Abstract] [Full Text] [Related]
4. Depressed immunity and the development of cancer.
Penn I
Clin Exp Immunol; 1981 Dec; 46(3):459-74. PubMed ID: 7039892
[No Abstract] [Full Text] [Related]
5. Primary immunodeficiency diseases and malignancy in Japan.
Hayakawa H; Kobayashi N; Yata J
Jpn J Cancer Res; 1986 Jan; 77(1):74-9. PubMed ID: 3082818
[TBL] [Abstract][Full Text] [Related]
6. [Primary immunodeficiency syndromes and malignant neoplasms].
Kobayashi N; Naitoh K; Kudo H; Matsui I; Hayakawa H; Yada J
Gan No Rinsho; 1987 Apr; 33(5 Suppl):495-500. PubMed ID: 3599459
[TBL] [Abstract][Full Text] [Related]
7. The occurrence of malignant tumors in immunosuppressed states.
Penn I
Prog Allergy; 1986; 37():259-300. PubMed ID: 3515352
[No Abstract] [Full Text] [Related]
8. Genetically determined immunodeficiency diseases (GDID) and malignancy: report from the immunodeficiency--cancer registry.
Spector BD; Perry GS; Kersey JH
Clin Immunol Immunopathol; 1978 Sep; 11(1):12-29. PubMed ID: 699386
[No Abstract] [Full Text] [Related]
9. Immunodeficiency and the pathogenesis of lymphoma and leukemia.
Louie S; Schwartz RS
Semin Hematol; 1978 Apr; 15(2):117-38. PubMed ID: 349695
[No Abstract] [Full Text] [Related]
10. Immunosurveillance and cancer: epidemiologic observations.
Fraumeni JF; Hoover R
Natl Cancer Inst Monogr; 1977 Dec; 47():121-6. PubMed ID: 349400
[TBL] [Abstract][Full Text] [Related]
11. Malignant disease in immunodeficient states in man.
Penn I
Recent Results Cancer Res; 1975; (52):96-106. PubMed ID: 796918
[No Abstract] [Full Text] [Related]
12. International Symposium on Hodgkin's disease. Session 1. Epidemiology and etiology. Part 4. Synthesis and epidemiological implications. Invited discussion: Synthesis and epidemiologic implications.
Miller RW
Natl Cancer Inst Monogr; 1973 May; 36():171-2. PubMed ID: 4270377
[No Abstract] [Full Text] [Related]
13. [The role of immunodeficiency in the pathogenesis of secondary lymphomas and leukemias].
Silobrcić V
Lijec Vjesn; 1983; 105(2-3):111-3. PubMed ID: 6855424
[No Abstract] [Full Text] [Related]
14. [Primary immunologic deficiencies and cancer. 5 anatomo-clinical case reports].
Mselati JC; Buriot D; Nezelof C
Arch Fr Pediatr; 1983 Mar; 40(3):163-9. PubMed ID: 6576732
[TBL] [Abstract][Full Text] [Related]
15. Editorial: Transfer-factor therapy of immunodeficiencies.
Polmar SH
N Engl J Med; 1973 Dec; 289(26):1420-1. PubMed ID: 4127762
[No Abstract] [Full Text] [Related]
16. Another look at immunologic surveillance.
Schwartz RS
N Engl J Med; 1975 Jul; 293(4):181-4. PubMed ID: 1094290
[No Abstract] [Full Text] [Related]
17. Immunodeficiency, immunosuppression, and susceptibility to neoplasms.
Schwartz RS
J Natl Cancer Inst Monogr; 2001; (28):5-9. PubMed ID: 11158200
[No Abstract] [Full Text] [Related]
18. Malignant neoplasms in registered cases of primary immunodeficiency syndrome.
Kobayashi N
Jpn J Clin Oncol; 1985 Apr; 15 Suppl 1():307-12. PubMed ID: 4009992
[TBL] [Abstract][Full Text] [Related]
19. Immunodeficiency and cancer: mechanisms involved.
Cottier H; Hess MW; Wälti ER
Schweiz Med Wochenschr; 1986 Aug; 116(34):1119-26. PubMed ID: 3532311
[TBL] [Abstract][Full Text] [Related]
20. [Studies on the epidemiology of malignant tumors, systemic diseases and leukemia in children (author's transl)].
Aurich G; Fuchs D; Herold HJ; Plenert W; Zintl F
Arch Geschwulstforsch; 1976; 46(2):116-28. PubMed ID: 1067061
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
